Search Results - "HOSING, C"

Oral lenalidomide with rituximab in relapsed or refractory diffuse large cell, follicular and transformed lymphoma: a phase II clinical trial by Wang, M, Fowler, N, Wagner-Bartak, N, Feng, L, Romaguera, J, Neelapu, S S, Hagemeister, F, Fanale, M, Oki, Y, Pro, B, Shah, J, Thomas, S, Younes, A, Hosing, C, Zhang, L, Newberry, K J, Desai, M, Cheng, N, Badillo, M, Bejarano, M, Chen, Y, Young, K H, Champlin, R, Kwak, L, Fayad, L

“…Lenalidomide–rituximab therapy is effective in grade 1–2 follicular and mantle cell lymphoma, but its efficacy in diffuse large B-cell lymphoma (DLBCL),…”
Get full text

Allogeneic stem-cell transplantation in patients with cutaneous lymphoma: updated results from a single institution by Hosing, C., Bassett, R., Dabaja, B., Talpur, R., Alousi, A., Ciurea, S., Popat, U., Qazilbash, M., Shpall, E.J., Oki, Y., Nieto, Y., Pinnix, C., Fanale, M., Maadani, F., Donato, M., Champlin, R., Duvic, M.

“…Cutaneous T-cell lymphomas (CTCLs) and its common variants mycosis fungoides (MF) and leukemic Sézary syndrome (SS) are rare extranodal non-Hodgkin's…”
Get full text

Long-term outcomes of Sleeping Beauty–generated CD19-specific CAR T-cell therapy for relapsed-refractory B-cell lymphomas by Srour, S.A., Singh, H., McCarty, J., de Groot, E., Huls, H., Rondon, G., Qazilbash, M., Ciurea, S., Bardelli, G., Buck, J., Alousi, A., Nieto, Y., Rezvani, K., Marin, D., Popat, U., Hosing, C., Shpall, E.J., Wierda, W.G., Kantarjian, H., Champlin, R.E., Cooper, L.J., Kebriaei, P.

Get full text

Transplantation of ex vivo expanded cord blood cells using the copper chelator tetraethylenepentamine: a phase I/II clinical trial by de Lima, M, McMannis, J, Gee, A, Komanduri, K, Couriel, D, Andersson, B S, Hosing, C, Khouri, I, Jones, R, Champlin, R, Karandish, S, Sadeghi, T, Peled, T, Grynspan, F, Daniely, Y, Nagler, A, Shpall, E J

“…The copper chelator tetraethylenepentamine (TEPA; StemEx) was shown to attenuate the differentiation of ex vivo cultured hematopoietic cells resulting in…”
Get full text

Characteristics, outcomes, prognostic factors and treatment of patients with T-cell prolymphocytic leukemia (T-PLL) by Jain, P., Aoki, E., Keating, M., Wierda, W.G., O’Brien, S., Gonzalez, G.N., Ferrajoli, A., Jain, N., Thompson, P.A., Jabbour, E., Kanagal-Shamanna, R., Pierce, S., Alousi, A., Hosing, C., Khouri, I., Estrov, Z., Cortes, J., Kantarjian, H., Ravandi, F., Kadia, T.M.

“…T-cell prolymphocytic leukemia (T-PLL) is a rare and aggressive disease. In this study, we report our experience from 119 patients with T-PLL. We reviewed the…”
Get full text

Multi-center analysis of the effect of T-cell acute lymphoblastic leukemia subtype and minimal residual disease on allogeneic stem cell transplantation outcomes by Brammer, J E, Saliba, R M, Jorgensen, J L, Ledesma, C, Gaballa, S, Poon, M, Maziarz, R T, Champlin, R E, Hosing, C, Kebriaei, P

“…This study aims to provide a detailed analysis of allogeneic stem cell transplantation (allo-SCT) outcomes in a large T-cell acute lymphoblastic leukemia…”
Get full text

Stem-cell transplantation in T-cell non-Hodgkin’s lymphomas by Hosing, C., Champlin, R.E.

“…T-cell lymphomas are a heterogeneous group of non-Hodgkin’s lymphomas (NHLs). With the exception of anaplastic lymphoma kinase protein-positive large-cell…”
Get full text

Hepatosplenic gamma-delta T-cell lymphoma: clinicopathological features and treatment by Falchook, G. S., Vega, F., Dang, N. H., Samaniego, F., Rodriguez, M. A., Champlin, R. E., Hosing, C., Verstovsek, S., Pro, B.

“…Background: Hepatosplenic T-cell lymphoma (HSTCL) is a rare peripheral T-cell lymphoma; treatment with standard anthracycline-containing chemotherapy regimens…”
Get full text

Umbilical cord blood graft engineering: challenges and opportunities by Thompson, P A, Rezvani, K, Hosing, C M, Oran, B, Olson, A L, Popat, U R, Alousi, A M, Shah, N D, Parmar, S, Bollard, C, Hanley, P, Kebriaei, P, Cooper, L, Kellner, J, McNiece, I K, Shpall, E J

“…We are entering a very exciting era in umbilical cord blood transplantation (UCBT), where many of the associated formidable challenges may become treatable by…”
Get full text

Adenoviral infections in adult allogeneic hematopoietic SCT recipients: a single center experience by Yilmaz, M, Chemaly, R F, Han, X Y, Thall, P F, Fox, P S, Tarrand, J J, De Lima, M J, Hosing, C M, Popat, U R, Shpall, E, Champlin, R E, Qazilbash, M H

“…Disseminated adenoviral infection (AI) is associated with profound immunosuppression and poor outcome after allogeneic hematopoietic SCT (allo-HSCT). A better…”
Get full text

Romidepsin targets multiple survival signaling pathways in malignant T cells by Valdez, B C, Brammer, J E, Li, Y, Murray, D, Liu, Y, Hosing, C, Nieto, Y, Champlin, R E, Andersson, B S

“…Romidepsin is a cyclic molecule that inhibits histone deacetylases. It is Food and Drug Administration-approved for treatment of cutaneous and peripheral…”
Get full text

Sirolimus in combination with tacrolimus and corticosteroids for the treatment of resistant chronic graft‐versus‐host disease by Couriel, D. R., Saliba, R., Escalón, M. P., Hsu, Y., Ghosh, S., Ippoliti, C., Hicks, K., Donato, M., Giralt, S., Khouri, I. F., Hosing, C., Lima, M. J., Andersson, B., Neumann, J., Champlin, R.

“…Summary Chronic graft‐versus‐host disease (cGVHD) remains a major cause of morbidity and mortality in haematopoietic transplant recipients. Sirolimus is a…”
Get full text

Donor type, in addition to transplantation in chronic phase and myeloablative conditioning, influence transplant survival for patients with advanced chronic myeloid leukemia in the era of tyrosine kinase inhibitors by Kongtim, P, Adekola, K, Milton, D R, Ramlal, R, Jimenez, A, Chen, J, Rondon, G, Ahmed, S, Kebriaei, P, Betul, O, Hosing, C M, Popat, U, Khouri, I, Jabbour, E, Cortes, J E, Kantarjian, H M, Champlin, R E, Ciurea, S O

Get full text

Outcomes of second allogeneic hematopoietic stem cell transplantation for patients with acute lymphoblastic leukemia by Poon, L M, Bassett Jr, R, Rondon, G, Hamdi, A, Qazilbash, M, Hosing, C, Jones, R B, Shpall, E J, Popat, U R, Nieto, Y, Worth, L L, Cooper, L, De Lima, M, Champlin, R E, Kebriaei, P

“…For patients with ALL who relapse following allo-SCT, only a second SCT provides a realistic chance for long-term disease remission. We retrospectively…”
Get full text

Phase I/II trial of lenalidomide and high-dose melphalan with autologous stem cell transplantation for relapsed myeloma by Shah, N, Thall, P F, Fox, P S, Bashir, Q, Shah, J J, Parmar, S, Lin, P, Kebriaei, P, Nieto, Y, Popat, U R, Hosing, C M, Cornelison, A, Shpall, E J, Orlowski, R Z, Champlin, R E, Qazilbash, M H

Get full text

Salvage Radiation Therapy Prior to Stem Cell Transplantation for Chemorefractory B-Cell Lymphoma by Pinnix, C.C, Dabaja, B, Milgrom, S.A, Smith, G.L, Reed, V.K, Arzu, I.Y, Westin, J.R, Rondon, G, Hosing, C, Nieto, Y, Ahmed, S

Get full text

Risk factors associated with late cytomegalovirus reactivation after allogeneic stem cell transplantation for hematological malignancies by ÖZDEMIR, E, SALIBA, R. M, SHPALL, E. J, QAZILBASH, M. H, MOLLDREM, J. J, CHEMALY, R. F, KOMANDURI, K. V, CHAMPLIN, R. E, COURIEL, D. R, GIRALT, S. A, DE LIMA, M, KHOURI, I. F, HOSING, C, KORNBLAU, S. M, ANDERLINI, P

“…We analyzed the clinical factors associated with late cytomegalovirus (CMV) reactivation in a group of 269 consecutive recipients of allogeneic stem cell…”
Get full text

Outcomes in hepatitis C virus seropositive lymphoma and myeloma patients after autologous stem cell transplantation by Varma, A, Saliba, R M, Torres, H A, Afrough, A, Hosing, C, Khouri, I F, Nieto, Y, Shah, N D, Parmar, S, Bashir, Q, Ahmed, S, Jones, R B, Kebriaei, P, Olson, A L, Shpall, E J, Alousi, A M, Qazilbash, M H, Champlin, R E, Popat, U

Get full text

Is there an expiration date for a cord blood unit in storage? by Parmar, S, de Lima, M, Worth, L, Petropoulos, D, Lee, D, Cooper, L, Kongtim, P, Alousi, A, Hosing, C, Popat, U, Kebriaei, P, McNiece, I, Shpall, E, Rondon, G, Champlin, R

Get full text

Autologous hematopoietic stem cell transplantation in light chain amyloidosis (AL) with renal involvement by Cornelison, A M, Saliba, R M, Afrough, A, Dinh, Y, Nieto, Y, Bashir, Q, Shah, N, Parmar, S, Hosing, C, Popat, U, Shpall, E, Champlin, R, Qazilbash, M H

Get full text